Shire “Encouraged” By Settlement Talks Over Adderall
The two companies are involved in litigation concerning Barr's efforts to market a copycat version of Shire's Adderall XR prior to the expiration of the Shire patents, which are not set to expire until 2018.
The two companies have remained tight-lipped concerning the negotiations, which have been ongoing since...
Already a subscriber? Click here to login